Skip to main content
. 2022 Jan 19;14(3):443. doi: 10.3390/nu14030443

Table 2.

Univariate analyses of outcomes between deprescribing and non-deprescribing group.

Total
(n = 91)
Deprescribing Group
(n = 39)
Non-Deprescribing Group
(n = 52)
p Value
Energy intake at discharge, kcal/kg/day, median (IQR) 29.1 (26.4–34.7) 30.5 (26.1–35.5) 28.6 (26.5–33.5) 0.227
Protein intake at discharge, g/kg/day, median (IQR) 1.2 (1.0–1.3) 1.2 (1.0–1.4) 1.2 (1.0–1.3) 0.912
HG at discharge, kg, median (IQR)
 Male 19.5 (14.4–25.1) 19.3 (15.5–24.1) 19.6 (14.2–25.4) 0.970
 Female 11 (5.9–22.4) 12.3 (6.1–14.6) 9.7 (0.0–14.1) 0.493
SMI at discharge, kg/m2, median (IQR)
 Male 6.2 (5.7–6.8) 6.0 (5.7–6.3) 6.4 (5.5–7.0) 0.248
 Female 4.9 (4.6–5.2) 4.8 (4.6–5.4) 4.9 (4.5–5.2) 0.985

HG, handgrip strength; IQR, interquartile Range; SMI, skeletal muscle mass index; SD, standard deviation.